title: Brain metastases in hormone refractory prostate cancer: a changing natural history?
authors.forename: R
authors.initials: R
authors.lastname: Roberts-Thomson
authors.forename: M A
authors.initials: MA
authors.lastname: Rosenthal
authors.forename: M
authors.initials: M
authors.lastname: Gonzales
authors.forename: K
authors.initials: K
authors.lastname: Drummond
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000473:pathology*; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000556:secondary* / Q000628:therapy; D003131:Combined Modality Therapy; D003399:Craniotomy; D019008:Drug Resistance, Neoplasm; D006801:Humans; D015192:Infratentorial Neoplasms / Q000556:secondary* / Q000628:therapy; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy / Q000473:pathology*; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000473:pathology*
chemical_list: D000970:Antineoplastic Agents